Eton Pharmaceuticals Q2 Net Income USD 11.578 Million
ETON•Quarterly earnings brief
Aug. 13 (Reuters) - Eton Pharmaceuticals Q2 EPS USD 0.35.
Related News
Health In Tech Q2 FY26 net loss widens to $2.5 million; revenue falls to $8.1 million
HIT•
Regional Management CEO Lakhbir S. Lamba buys USD 316,645 of common shares
RM•
Aurora Innovation director Michelangelo Volpi disposes of Class A shares worth $10.22 million
AUR•
Caliber Q2 FY26 net loss narrows to USD 3.4 million; platform revenue falls to USD 3.7 million
CWD•
Kustom Entertainment issues 2,625,000 shares in unregistered private placement for services, debt and asset deals
KUST•